I-Patent entsha yase-US Yokuthola i-PTSD Ezifundweni Eziphilayo

Ibhalwe ngu umhleli

I-Neurovation Labs, Inc., inkampani ye-biotech eqondise ama-biomarker aphathekayo e-PTSD ukuze axilongwe futhi alashwe ngokugcwele, namuhla imemezele ukuthi Ihhovisi Legunya Lobunikazi Nezimpawu Zokuhweba lase-US likhiphe I-US Patent No. 11,224,668, ngoJanuwari 18, 2022.

Phrinta Friendly, PDF & Imeyili

Ilungelo lobunikazi, elinesihloko esithi “Ukwakheka Nezindlela Zokubona i-GluA1 ebuchosheni kanye Nokuhlonza Ubukhona Be-GluA1-Mediated PTSD,” liqondiswe ekuqanjweni kwamanoveli nezindlela zokuxilonga i-PTSD kanye nokwelapha i-PTSD ngemva kokuxilongwa okunjalo.              

“Inhlanganisela evikelwe yile lungelo lobunikazi ivela kolunye lochungechunge lwamakilasi i-Neurovation Labs eyakhayo ukuze kutholakale umgomo wokuxilonga i-PTSD kanye nokuhlola kangcono izindlela eziyisisekelo ze-PTSD nezinye izinkinga zempilo yengqondo. Lezi zinhlanganisela nezindlela ezihambisanayo ezimbozwe yilungelo lobunikazi zimele inoveli, indlela eqondiwe empilweni yengqondo kanye nokubona ngeso lengqondo ukuphazamiseka okuphakathi kobuchopho,” kusho uDkt. Jennifer Perusini, Umsunguli kanye Nesikhulu Esiphezulu senkampani.

Le patent iphethwe yi-Neurovation Labs kuphela futhi ingeyokuqala ekhishwe kwiphothifoliyo ebanzi yempahla yengqondo esukela ocwaningweni nasekuthuthukisweni kwenkampani.

Phrinta Friendly, PDF & Imeyili

Mayelana umbhali

umhleli

Umhleli omkhulu we-eTurboNew nguLinda Hohnholz. Uzinze e-eTN HQ e-Honolulu, e-Hawaii.

Shiya amazwana

eTurboNews | eTN